You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recommended phase 2 dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Brain Tumor Trial in Houston (tepotinib, tepotinib plus osimertinib)

Not yet recruiting
  • Brain Tumor
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Advanced Solid Tumors With MAPK Pathway Mutations Trial in Nedlands (D3S-002)

Not yet recruiting
  • Advanced Solid Tumors With MAPK Pathway Mutations
  • Nedlands, Western Australia, Australia
    D3 Bio Investigative Site
May 24, 2023

Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma Trial (Lurbinectedin)

Not yet recruiting
  • Refractory Ewing Sarcoma
  • +2 more
  • (no location specified)
Feb 15, 2023

Prostate Cancer Trial (BP-C2)

Not yet recruiting
  • Prostate Cancer
  • (no location specified)
Jan 10, 2023

Advanced Solid Tumor Trial (HLX23)

Withdrawn
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Jan 13, 2023

Glioblastoma Trial in Milwaukee (Gallium maltolate (500 mg), Gallium maltolate (1,000 mg), Gallium maltolate (1,500 mg))

Recruiting
  • Glioblastoma
  • Gallium maltolate (500 mg)
  • +3 more
  • Milwaukee, Wisconsin
    Froedtert Hospital & the Medical College of Wisconsin
Sep 20, 2022

Advanced Cancer, Metastatic Cancer Trial (Q901)

Recruiting
  • Advanced Cancer
  • Metastatic Cancer
  • Phoenix, Arizona
  • +5 more
Sep 1, 2022

Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

Not yet recruiting
  • Cancer
  • +3 more
  • 177Lu-PSMA-I&T - escalating renal absorbed dose
  • 177Lu-PSMA-I&T - recommended phase 2 regime
  • (no location specified)
Jun 14, 2023

Malignant Pleural Effusion, Malignant Pleural Mesothelioma, Mesothelioma Trial in Leicester (RSO-021)

Recruiting
  • Malignant Pleural Effusion
  • +3 more
  • Leicester, United Kingdom
  • +5 more
Oct 28, 2022

Squamous Cell Carcinoma of Head and Neck, Colo-rectal Cancer, Non Small Cell Lung Cancer Trial in Aurora, Nashville, Houston

Recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • +4 more
  • Aurora, Colorado
  • +2 more
Apr 18, 2022

IDH1-mutant Cholangiocarcinoma Trial (Ivosidenib, Recommended Combination Dose (RCD) of ivosidenib, Nivolumab)

Not yet recruiting
  • IDH1-mutant Cholangiocarcinoma
  • (no location specified)
Jun 29, 2023

Solid Tumor Trial in Italy, United States (Derazantinib low dose range, Derazantinib middle dose range, Derazantinib high dose

Completed
Has Results
  • Solid Tumor
  • Derazantinib low dose range
  • +3 more
  • Scottsdale, Arizona
  • +11 more
Mar 7, 2022

Covid19 Trial in Hakata (DS-5670a, Placebo)

Completed
  • Covid19
  • DS-5670a
  • Placebo
  • Hakata, Fukuoka, Japan
    SOUSEIKAI Hakata Clinic
Aug 29, 2022

Tumors Trial in Worldwide (GSK3845097, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Jul 5, 2023

Advanced Solid Tumor Trial in Seoul (ABL501)

Recruiting
  • Advanced Solid Tumor
  • Seoul, Korea, Republic of
  • +3 more
Oct 31, 2021

Ovarian Cancer Trial in Boston, Copenhagen (Niraparib, Bevacizumab)

Completed
  • Ovarian Cancer
  • Boston, Massachusetts
  • +1 more
Jan 7, 2022

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Tumors Trial in Worldwide (GSK3901961, Cyclophosphamide, Fludarabine)

Terminated
  • Neoplasms
  • New Haven, Connecticut
  • +20 more
Sep 15, 2023

Advanced Solid Tumor Trial in United States (ABL503)

Recruiting
  • Advanced Solid Tumor
  • Duarte, California
  • +4 more
Oct 5, 2021

Advanced or Metastatic Solid Tumor Trial in Worldwide (Rogaratinib (BAY1163877), Copanlisib (BAY80-6946))

Completed
  • Advanced or Metastatic Solid Tumor
  • Rogaratinib (BAY1163877)
  • Copanlisib (BAY80-6946)
  • Los Angeles, California
  • +19 more
Jul 13, 2022

Hepatocellular Carcinoma, Liver Cancer, Liver Tumor Trial in United States (ET140203 autologous T cell product)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • ET140203 autologous T cell product
  • Duarte, California
  • +3 more
Jul 1, 2022

AL Amyloidosis, Amyloidosis Trial in Stanford, Boston, Rochester (Belantamab mafodotin 2.5 mg/kg (6 weeks), Belantamab mafodotin

Not yet recruiting
  • AL Amyloidosis
  • Amyloidosis
  • Belantamab mafodotin 2.5 mg/kg (6 weeks)
  • +4 more
  • Stanford, California
  • +3 more
Jul 25, 2022

Advanced Solid Tumors Trial in Worldwide (Elimusertib (BAY1895344), Pembrolizumab)

Active, not recruiting
  • Advanced Solid Tumors
  • Palo Alto, California
  • +15 more
Jan 6, 2023

Lymphoma, Non-Hodgkin Trial in Canada, United States (TAK-659, Bendamustine, Rituximab)

Terminated
Has Results
  • Lymphoma, Non-Hodgkin
  • Tucson, Arizona
  • +12 more
Dec 7, 2021

Advanced Solid Tumors Cancer Trial in Worldwide (ABBV-151, Budigalimab)

Recruiting
  • Advanced Solid Tumors Cancer
  • New Haven, Connecticut
  • +29 more
Dec 5, 2022